2 stories about BiondVax
ביונדווקס BiondVax תמר בן ידידיה רון בבקוב

Flu Season Might Soon Pass, for Good

11.12.19|Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
מריוס נכט 2

Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax

17.07.19|Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials